Background: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) improves clinical outcomes and quality of life.
Read moreBackground: Alignment between clinician-reported New York Heart Association (NYHA) class compared and patient-reported outcomes among patients hospitalized for heart failure
Read moreBackground: The impact of the COVID-19 pandemic on participation in and availability of cardiac rehabilitation (CR) is unknown. Methods: Among
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreKeerthi T. Gondi Correspondence to: Keerthi T. Gondi, MD, Department of Internal Medicine, University of Michigan Health System, 1500 E
Read moreChiadi E. Ndumele * Corresponding Author; email: E-mail Address: [email protected] Johns Hopkins Ciccarone Center for the Prevention of Heart Disease,
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Dilated cardiomyopathy (DCM) is a life-threatening disease, resulting in refractory heart failure. An immune
Read moreBackground: Racial disparities in access to advanced therapies for heart failure (HF) patients are well documented, although the reasons remain
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link
Read moreBackground: Understanding how statins, ezetimibe, and PCSK9i (proprotein convertase subtilisin/kexin type 9 serine protease inhibitors) are prescribed after a myocardial
Read more
